Sideways killing mediated by either anti-TCR or anti-T3 antibodies: use of both high and low avidity Fc receptor and cell adhesion molecules.
Ito
M
M
Department of Microbiology, Mount Sinai School of Medicine, New York, NY 10029.
Moran
T M
TM
D000818:Animals; D000943:Antigens, Differentiation / Q000502:physiology; D000945:Antigens, Differentiation, T-Lymphocyte / Q000502:physiology*; D017252:CD3 Complex; D015815:Cell Adhesion Molecules / Q000502:physiology; D002999:Clone Cells; D003602:Cytotoxicity, Immunologic / Q000502:physiology*; D006801:Humans; D007132:Immunoglobulin Isotypes / Q000378:metabolism; D011948:Receptors, Antigen, T-Cell / Q000502:physiology*; D011961:Receptors, Fc / Q000502:physiology; D017452:Receptors, IgG
D000943:Antigens, Differentiation; D000945:Antigens, Differentiation, T-Lymphocyte; D017252:CD3 Complex; D015815:Cell Adhesion Molecules; D007132:Immunoglobulin Isotypes; D011948:Receptors, Antigen, T-Cell; D011961:Receptors, Fc; D017452:Receptors, IgG